| Entry |
|
| Name |
NRG-ERBB2/ERBB3 pathway (P13K signaling)
|
| Definition |
NRG -- ERBB3 -- ERBB2 -> PI3K -> PIP3 -> AKT -> MTOR |
| Expanded |
(3084,9542) -- 2065 -- 2064 -> (5290,5291,5293) -> C05981 -> (207,208,10000) -> 2475 |
| Class |
|
| Type |
Reference
|
| Pathway |
|
| Gene |
| 2065 | ERBB3; erb-b2 receptor tyrosine kinase 3 |
| 2064 | ERBB2; erb-b2 receptor tyrosine kinase 2 |
| 5290 | PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
| 5291 | PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
| 5293 | PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
| 207 | AKT1; AKT serine/threonine kinase 1 |
| 208 | AKT2; AKT serine/threonine kinase 2 |
| 10000 | AKT3; AKT serine/threonine kinase 3 |
| 2475 | MTOR; mechanistic target of rapamycin kinase |
|
| Metabolite |
| C05981 | Phosphatidylinositol-3,4,5-trisphosphate |
|
| Reference |
|
| Authors |
Black LE, Longo JF, Carroll SL |
| Title |
Mechanisms of Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3) Action in Human Neoplasia. |
| Journal |
|
| Reference |
|
| Authors |
Zhang C, Mei W, Zeng C |
| Title |
Oncogenic Neuregulin 1 gene (NRG1) fusions in cancer: A potential new therapeutic opportunities. |
| Journal |
|
| LinkDB |
|